Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,226) with videos related to
Page
of 123
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Frontiers in Immunology
|
January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model
J Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Metabolic Engineering
|
July 10, 2021
Engineering improved ethylene production: Leveraging systems biology and adaptive laboratory evolution
Sophie Vaud, Nicole Pearcy, Marko Hanževački, et al.
Veterinary and Comparative Oncology
|
January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours
C London, T Mathie, N Stingle, et al.
The Journal of Clinical Investigation
|
September 26, 2023
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
Stephen Jun Fei Chong, Fen Zhu, Olga Dashevsky, et al.
British Journal of Cancer
|
November 23, 2006
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L L Villa, R L R Costa, C A Petta, et al.
Science Advances
|
March 15, 2024
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness
Xiaodan Qin, Andrew Lam, Xu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Nature
|
May 4, 2022
Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanoma
Giacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.
Page
of 123
Search research articles
Search
Showing results (1201-1210 of 1,226) with videos related to
Sort By:
Page
of 123
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2024
Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
Mary Jane Lim-Fat, J Bryan Iorgulescu, Rifaquat Rahman, et al.
Frontiers in Immunology
|
January 12, 2024
Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model
J Bryan Iorgulescu, Neil Ruthen, Ryuhjin Ahn, et al.
Metabolic Engineering
|
July 10, 2021
Engineering improved ethylene production: Leveraging systems biology and adaptive laboratory evolution
Sophie Vaud, Nicole Pearcy, Marko Hanževački, et al.
Veterinary and Comparative Oncology
|
January 13, 2012
Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours
C London, T Mathie, N Stingle, et al.
The Journal of Clinical Investigation
|
September 26, 2023
Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies
Stephen Jun Fei Chong, Fen Zhu, Olga Dashevsky, et al.
British Journal of Cancer
|
November 23, 2006
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L L Villa, R L R Costa, C A Petta, et al.
Science Advances
|
March 15, 2024
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness
Xiaodan Qin, Andrew Lam, Xu Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2020
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
J Bryan Iorgulescu, Prafulla C Gokhale, Maria C Speranza, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2023
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
Meenal Datta, Sampurna Chatterjee, Elizabeth M Perez, et al.
Nature
|
May 4, 2022
Landscape of helper and regulatory antitumour CD4<sup>+</sup> T cells in melanoma
Giacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.
Page
of 123